Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

  1. Teerlink, J.R.
  2. Diaz, R.
  3. Michael Felker, G.
  4. McMurray, J.J.V.
  5. Metra, M.
  6. Solomon, S.D.
  7. Adams, K.F.
  8. Anand, I.
  9. Arias-Mendoza, A.
  10. Biering-Sorensen, T.
  11. Bohm, M.
  12. Bonderman, D.
  13. Cleland, J.G.F.
  14. Corbalan, R.
  15. Crespo-Leiro, M.G.
  16. Dahlstrom, U.
  17. Echeverria, L.E.
  18. Fang, J.C.
  19. Filippatos, G.
  20. Fonseca, C.
  21. Goncalvesova, E.
  22. Goudev, A.R.
  23. Howlett, J.G.
  24. Lanfear, D.E.
  25. Li, J.
  26. Lund, M.
  27. Macdonald, P.
  28. Mareev, V.
  29. Momomura, S.
  30. O'Meara, E.
  31. Parkhomenko, A.
  32. Ponikowski, P.
  33. Ramires, F.J.A.
  34. Serpytis, P.
  35. Sliwa, K.
  36. Spinar, J.
  37. Suter, T.M.
  38. Tomcsanyi, J.
  39. Vandekerckhove, H.
  40. Vinereanu, D.
  41. Voors, A.A.
  42. Yilmaz, M.B.
  43. Zannad, F.
  44. Sharpsten, L.
  45. Legg, J.C.
  46. Varin, C.
  47. Honarpour, N.
  48. Abbasi, S.A.
  49. Malik, F.I.
  50. Kurtz, C.E.
  51. Show all authors +
Journal:
New England Journal of Medicine

ISSN: 1533-4406 0028-4793

Year of publication: 2021

Volume: 384

Issue: 2

Pages: 105-116

Type: Article

DOI: 10.1056/NEJMOA2025797 GOOGLE SCHOLAR

Sustainable development goals